Literature DB >> 10587705

Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia.

R H Edwards1, M A Wasik, J Finan, R Rodriguez, J Moore, M Kamoun, H Rennert, J Bird, P C Nowell, K E Salhany.   

Abstract

Acute promyelocytic leukemia (APL) represents a subtype of acute myeloid leukemia with characteristic morphologic, molecular, and immunophenotypic features. Previous immunophenotypic analyses have shown that leukemic cells in APL typically express the myeloid markers CD33 and CD13 but lack expression of the early hematopoietic progenitor cell antigens CD34 and HLA-DR. We analyzed selected immunophenotypic features of APL by flow cytometry and showed that 7 (41%) of 17 cases contained significant subsets of CD34+ leukemic cells: CD34+ myeloid cells predominated in 2 APL cases. By using a fluorescence-activated cell sorter-fluorescence in situ hybridization approach, we confirmed that the CD34+ cells harbored the t(15;17) translocation characteristic of APL. By using the same experimental approach, CD34+ populations were stratified into primitive CD34+ CD38- and committed CD34+ CD38+ progenitor cell subpopulations; cells in both subsets contained the t(15;17) translocation. The knowledge that APL may be partly or largely CD34+ is important for proper diagnosis. Furthermore, identification of the t(15;17) translocation in CD34+ CD38- blasts indicates that, in at least some cases, the leukemogenic mutation in APL occurs within primitive hematopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587705     DOI: 10.1093/ajcp/112.6.819

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.

Authors:  G K Przybylski; H Wu; W R Macon; J Finan; D G Leonard; R E Felgar; J A DiGiuseppe; P C Nowell; S H Swerdlow; M E Kadin; M A Wasik; K E Salhany
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.

Authors:  D B Zimonjic; J L Pollock; P Westervelt; N C Popescu; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 3.  Antagonizing RARγ Drives Necroptosis of Cancer Stem Cells.

Authors:  Geoffrey Brown
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

4.  PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors.

Authors:  S Wojiski; F C Guibal; T Kindler; B H Lee; J L Jesneck; A Fabian; D G Tenen; D G Gilliland
Journal:  Leukemia       Date:  2009-03-26       Impact factor: 11.528

Review 5.  Oncogenes and the Origins of Leukemias.

Authors:  Geoffrey Brown
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

Review 6.  Lessons to cancer from studies of leukemia and hematopoiesis.

Authors:  Geoffrey Brown
Journal:  Front Cell Dev Biol       Date:  2022-09-20

Review 7.  Hematopoietic Stem Cells: Nature and Niche Nurture.

Authors:  Geoffrey Brown
Journal:  Bioengineering (Basel)       Date:  2021-05-15

Review 8.  Lineage Decision-Making within Normal Haematopoietic and Leukemic Stem Cells.

Authors:  Geoffrey Brown; Lucía Sánchez; Isidro Sánchez-García
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

Review 9.  Are Leukaemic Stem Cells Restricted to a Single Cell Lineage?

Authors:  Geoffrey Brown; Lucía Sánchez; Isidro Sánchez-García
Journal:  Int J Mol Sci       Date:  2019-12-19       Impact factor: 5.923

Review 10.  The RARγ Oncogene: An Achilles Heel for Some Cancers.

Authors:  Geoffrey Brown; Kevin Petrie
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.